GLP-1-Exendin-4/IgG4 (Fc) Fusion Protein as a Novel Drug for Diabetes Treatment-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

GLP-1-Exendin-4/IgG4 (Fc) Fusion Protein as a Novel Drug for Diabetes Treatment

Published:2015-04-21 Issue:06 Volume:123 Page:371-375
ISSN:0947-7349
Container-title:Experimental and Clinical Endocrinology & Diabetes
language:en
Short-container-title:Exp Clin Endocrinol Diabetes

Author:

Gan Y.¹,Dang N.¹,Qu Z.¹,Shi R.¹,Ding L.¹,Wang L.¹,Pang S.¹

Affiliation:

1. Jinan Central Hospital Affiliated to Shandong University, Jinan Shandong Province, People’s Republic of China

Publisher

Georg Thieme Verlag KG

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-0035-1548797.pdf

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The construction of long-acting exendin-4 analog and its hypoglycemic effect in diabetic mice;Protein Expression and Purification;2024-01

2. Chloroplast transformation for bioencapsulation and oral delivery using the immunoglobulin G fragment crystallizable (Fc) domain;Scientific Reports;2023-11-02

3. Irisin as an agent for protecting against osteoporosis: A review of the current mechanisms and pathways;Journal of Advanced Research;2023-09

4. Construction of multicopy glucagon-like peptide-1 (GLP-1) open reading frame and its expression in Escherichia coli;AIP Conference Proceedings;2023

5. Irisin ameliorates age‐associated sarcopenia and metabolic dysfunction;Journal of Cachexia, Sarcopenia and Muscle;2022-12-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP